{"id":531044,"date":"2021-08-24T16:08:36","date_gmt":"2021-08-24T20:08:36","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/rxsight-to-report-second-quarter-2021-financial-results-on-september-7-2021\/"},"modified":"2021-08-24T16:08:36","modified_gmt":"2021-08-24T20:08:36","slug":"rxsight-to-report-second-quarter-2021-financial-results-on-september-7-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/rxsight-to-report-second-quarter-2021-financial-results-on-september-7-2021\/","title":{"rendered":"RxSight to Report Second Quarter 2021 Financial Results on September 7, 2021\u00a0"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">ALISO VIEJO, Calif., Aug.  24, 2021  (GLOBE NEWSWIRE) &#8212; RxSight, Inc., an ophthalmic medical device company, today announced that it will report financial results for the second quarter of 2021 after the market close on Tuesday, September 7, 2021. The company\u2019s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time \/ 4:30 p.m. Eastern Time.<\/p>\n<p>Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jhaXgs-V9ski8nWcX94sfhJwwv538HXn_4xRFGR8y8ZCuCrFwidnQdCP8Ce8FoNqTT4mVs-fD6ZiVaujU-hJ0obB8N_gsT1C09Cq6VtrhLpCsu8Bt73-ViDnf9hG71LH\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/investors.rxsight.com\/<\/a>.<\/p>\n<p>\n        <strong>About RxSight, Inc.<\/strong><br \/>\n        <br \/>RxSight, Inc. is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. The RxSight Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens (LAL<sup>\u00ae<\/sup>), RxSight Light Delivery Device (LDD\u2122) and accessories, is the first and only commercially available intraocular lens (IOL) technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The LAL now features ActivShield\u2122 technology, a revolutionary UV protection layer built into the lens. Additional information about RxSight can be found at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=InRwUtlGPYKoT7Gkx_ms6AidJcPmhDIK3retLlqq2i79iAGyxohbREjQ07J9lr4f8Vq4DZY9HXdHqCUTJ2dKIg==\" rel=\"nofollow noopener\" target=\"_blank\">www.rxsight.com<\/a>.<\/p>\n<p>\n        <strong>Investor Relations Contact:<\/strong><br \/>\n        <br \/>Philip Taylor <br \/>Gilmartin Group<br \/>415.937.5406<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pAdxN_xofntkPENNJrrC1OAhNTHyM6rVsbM2Dj-V5jDqpblJVPqYVWlI50ul4L9Kt3cOB-802tmknSTvFdm-TA==\" rel=\"nofollow noopener\" target=\"_blank\">IR@rxsight.com<\/a><\/p>\n<p>\n        <strong>Company contact:<\/strong><br \/>\n        <br \/>Roy Freeman<br \/>Sr. Director, Marketing<br \/>rfreeman@rxsight.com<\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxNDQ1NSM0MzczMTkwIzIyMTAxNDU=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/OTZmYzVhNjUtY2QzNi00ZTRlLTk0ZDgtZDA3OTllMTcxOWJkLTEyMjE2OTg=\/tiny\/Rxsight-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ALISO VIEJO, Calif., Aug. 24, 2021 (GLOBE NEWSWIRE) &#8212; RxSight, Inc., an ophthalmic medical device company, today announced that it will report financial results for the second quarter of 2021 after the market close on Tuesday, September 7, 2021. The company\u2019s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time \/ 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at https:\/\/investors.rxsight.com\/. About RxSight, Inc. RxSight, Inc. is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. The RxSight Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens (LAL\u00ae), RxSight &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/rxsight-to-report-second-quarter-2021-financial-results-on-september-7-2021\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;RxSight to Report Second Quarter 2021 Financial Results on September 7, 2021\u00a0&#8220;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-531044","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>RxSight to Report Second Quarter 2021 Financial Results on September 7, 2021\u00a0 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/rxsight-to-report-second-quarter-2021-financial-results-on-september-7-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"RxSight to Report Second Quarter 2021 Financial Results on September 7, 2021\u00a0 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ALISO VIEJO, Calif., Aug. 24, 2021 (GLOBE NEWSWIRE) &#8212; RxSight, Inc., an ophthalmic medical device company, today announced that it will report financial results for the second quarter of 2021 after the market close on Tuesday, September 7, 2021. The company\u2019s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time \/ 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at https:\/\/investors.rxsight.com\/. About RxSight, Inc. RxSight, Inc. is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. The RxSight Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens (LAL\u00ae), RxSight &hellip; Continue reading &quot;RxSight to Report Second Quarter 2021 Financial Results on September 7, 2021\u00a0&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/rxsight-to-report-second-quarter-2021-financial-results-on-september-7-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-24T20:08:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxNDQ1NSM0MzczMTkwIzIyMTAxNDU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rxsight-to-report-second-quarter-2021-financial-results-on-september-7-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rxsight-to-report-second-quarter-2021-financial-results-on-september-7-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"RxSight to Report Second Quarter 2021 Financial Results on September 7, 2021\u00a0\",\"datePublished\":\"2021-08-24T20:08:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rxsight-to-report-second-quarter-2021-financial-results-on-september-7-2021\\\/\"},\"wordCount\":202,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rxsight-to-report-second-quarter-2021-financial-results-on-september-7-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxNDQ1NSM0MzczMTkwIzIyMTAxNDU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rxsight-to-report-second-quarter-2021-financial-results-on-september-7-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rxsight-to-report-second-quarter-2021-financial-results-on-september-7-2021\\\/\",\"name\":\"RxSight to Report Second Quarter 2021 Financial Results on September 7, 2021\u00a0 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rxsight-to-report-second-quarter-2021-financial-results-on-september-7-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rxsight-to-report-second-quarter-2021-financial-results-on-september-7-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxNDQ1NSM0MzczMTkwIzIyMTAxNDU=\",\"datePublished\":\"2021-08-24T20:08:36+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rxsight-to-report-second-quarter-2021-financial-results-on-september-7-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rxsight-to-report-second-quarter-2021-financial-results-on-september-7-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rxsight-to-report-second-quarter-2021-financial-results-on-september-7-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxNDQ1NSM0MzczMTkwIzIyMTAxNDU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxNDQ1NSM0MzczMTkwIzIyMTAxNDU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rxsight-to-report-second-quarter-2021-financial-results-on-september-7-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"RxSight to Report Second Quarter 2021 Financial Results on September 7, 2021\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"RxSight to Report Second Quarter 2021 Financial Results on September 7, 2021\u00a0 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/rxsight-to-report-second-quarter-2021-financial-results-on-september-7-2021\/","og_locale":"en_US","og_type":"article","og_title":"RxSight to Report Second Quarter 2021 Financial Results on September 7, 2021\u00a0 - Market Newsdesk","og_description":"ALISO VIEJO, Calif., Aug. 24, 2021 (GLOBE NEWSWIRE) &#8212; RxSight, Inc., an ophthalmic medical device company, today announced that it will report financial results for the second quarter of 2021 after the market close on Tuesday, September 7, 2021. The company\u2019s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time \/ 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at https:\/\/investors.rxsight.com\/. About RxSight, Inc. RxSight, Inc. is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. The RxSight Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens (LAL\u00ae), RxSight &hellip; Continue reading \"RxSight to Report Second Quarter 2021 Financial Results on September 7, 2021\u00a0\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/rxsight-to-report-second-quarter-2021-financial-results-on-september-7-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-08-24T20:08:36+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxNDQ1NSM0MzczMTkwIzIyMTAxNDU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rxsight-to-report-second-quarter-2021-financial-results-on-september-7-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rxsight-to-report-second-quarter-2021-financial-results-on-september-7-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"RxSight to Report Second Quarter 2021 Financial Results on September 7, 2021\u00a0","datePublished":"2021-08-24T20:08:36+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rxsight-to-report-second-quarter-2021-financial-results-on-september-7-2021\/"},"wordCount":202,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rxsight-to-report-second-quarter-2021-financial-results-on-september-7-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxNDQ1NSM0MzczMTkwIzIyMTAxNDU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rxsight-to-report-second-quarter-2021-financial-results-on-september-7-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/rxsight-to-report-second-quarter-2021-financial-results-on-september-7-2021\/","name":"RxSight to Report Second Quarter 2021 Financial Results on September 7, 2021\u00a0 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rxsight-to-report-second-quarter-2021-financial-results-on-september-7-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rxsight-to-report-second-quarter-2021-financial-results-on-september-7-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxNDQ1NSM0MzczMTkwIzIyMTAxNDU=","datePublished":"2021-08-24T20:08:36+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rxsight-to-report-second-quarter-2021-financial-results-on-september-7-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/rxsight-to-report-second-quarter-2021-financial-results-on-september-7-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rxsight-to-report-second-quarter-2021-financial-results-on-september-7-2021\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxNDQ1NSM0MzczMTkwIzIyMTAxNDU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxNDQ1NSM0MzczMTkwIzIyMTAxNDU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rxsight-to-report-second-quarter-2021-financial-results-on-september-7-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"RxSight to Report Second Quarter 2021 Financial Results on September 7, 2021\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/531044","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=531044"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/531044\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=531044"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=531044"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=531044"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}